IKT logo

Inhibikase Therapeutics (IKT) Shareholders Equity

Annual Shareholders Equity

$10.98 M
-$10.06 M-47.81%

December 31, 2023


Summary


Performance

IKT Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKTbalance sheetmetrics:

Quarterly Shareholders Equity

-$530.60 K
-$5.63 M-110.41%

September 30, 2024


Summary


Performance

IKT Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKTbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

IKT Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-47.8%-110.4%
3 y3 years+12.2%-102.1%
5 y5 years+1511.0%-102.1%

IKT Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-71.4%at low-101.4%at low
5 y5-year-71.4%+344.5%-101.1%+89.7%
alltimeall time-71.4%+344.5%-101.1%+89.7%

Inhibikase Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
-$530.60 K(-110.4%)
Jun 2024
-
$5.10 M(-24.8%)
Mar 2024
-
$6.78 M(-38.3%)
Dec 2023
$10.98 M(-47.8%)
$10.98 M(-26.9%)
Sep 2023
-
$15.02 M(-22.8%)
Jun 2023
-
$19.46 M(-23.1%)
Mar 2023
-
$25.32 M(+20.4%)
Dec 2022
$21.04 M
$21.04 M(-16.3%)
Sep 2022
-
$25.14 M(-14.8%)
Jun 2022
-
$29.50 M(-13.3%)
DateAnnualQuarterly
Mar 2022
-
$34.01 M(-11.5%)
Dec 2021
$38.42 M(+292.6%)
$38.42 M(-11.0%)
Sep 2021
-
$43.16 M(-8.3%)
Jun 2021
-
$47.05 M(+485.5%)
Mar 2021
-
$8.04 M(-17.9%)
Dec 2020
$9.78 M(-317.9%)
$9.78 M(-290.9%)
Sep 2020
-
-$5.13 M(+6.1%)
Jun 2020
-
-$4.83 M(+2.7%)
Mar 2020
-
-$4.70 M(+4.7%)
Dec 2019
-$4.49 M(+477.1%)
-$4.49 M
Dec 2018
-$778.00 K
-

FAQ

  • What is Inhibikase Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Inhibikase Therapeutics?
  • What is Inhibikase Therapeutics annual shareholders equity year-on-year change?
  • What is Inhibikase Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Inhibikase Therapeutics?
  • What is Inhibikase Therapeutics quarterly shareholders equity year-on-year change?

What is Inhibikase Therapeutics annual stockholders equity?

The current annual shareholders equity of IKT is $10.98 M

What is the all time high annual shareholders equity for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high annual stockholders equity is $38.42 M

What is Inhibikase Therapeutics annual shareholders equity year-on-year change?

Over the past year, IKT annual stockholders equity has changed by -$10.06 M (-47.81%)

What is Inhibikase Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of IKT is -$530.60 K

What is the all time high quarterly shareholders equity for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high quarterly stockholders equity is $47.05 M

What is Inhibikase Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, IKT quarterly stockholders equity has changed by -$5.63 M (-110.41%)